Zobrazeno 1 - 10
of 124
pro vyhledávání: '"M Ostronoff"'
Autor:
M Ostronoff, Jose Luis Pico, Jean Pierre Droz, Erard Gilles, Edmilson Zambon, D. Baume, Patrice Carde, A Moran, M. Hayat
Publikováno v:
Cancer Investigation. 8:1-5
Thirty adult patients with relapsed or refractory malignant lymphoma underwent a Phase I-II trial of salvage chemotherapy combining methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI protocol). All patients had been extensively pretreated. At
Autor:
R S Medeiros, Roberto Luiz da Silva, Clarisse Martins Machado, M. C. M. A. Macedo, Jussara Bianchi Castelli, Frederico Luiz Dulley, M Ostronoff, A C M Silva, C M Massumoto
Publikováno v:
Acta Haematologica. 99:54-56
Patients undergoing immunosuppressive therapy have a 21% risk of developing Pneumocystis carinii pneumonia (PCP) if no prophylaxis is used [1]. During the first 6 months after bone marrow transplantation (BMT), the recipients have an estimated 9% ris
Autor:
Frederico Rafael Moreira, Lucia Mariano da Rocha Silla, Angelo Maiolino, Marcio Nucci, Henrique Neves da Silva Bittencourt, Júlio César Voltarelli, Daniela C. Setubal, Ricardo Pasquini, Lilian Piron-Ruiz, Yana N. Sarquis, Silvia Regina Brandalise, Nadjanara D. Bueno, Afonso Celso Vigorito, Maria Aparecida Zanichelli, Nelson Hamerschlak, Mair Pedro de Souza, Vergilio A.R. Colturato, Adriana Seber, M Ostronoff, Marco Antônio S. Rotolo, Euripedes Ferreira, Carmino Antonio De Souza, M.A. Ruiz, Erika Coelho, Belinda Pinto Simões, Debora Barton, Cláudio Galvão de Castro
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Volume: 28, Issue: 1, Pages: 11-18, Published: MAR 2006
Revista Brasileira de Hematologia e Hemoterapia v.28 n.1 2006
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Revista Brasileira de Hematologia e Hemoterapia v.28 n.1 2006
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Dados do Registro Internacional de Transplante de Medula Óssea, International Bone Marrow Transplant Registry (IBMTR) contribuem para o progresso do transplante de medula óssea (TMO) em todo o mundo. Neste artigo relatamos a experiência brasileira
Autor:
Kelen C. R. Malmegrim, M Ostronoff, Nelson Hamerschlak, Daniela A. Moraes, D Sturaro, Marina A. Coutinho, Júlio César Voltarelli, Frederico Luiz Dulley, C M Massumoto, Morton Scheinberg, Belinda Pinto Simões, Maria Carolina Oliveira, Ana Beatriz P.L. Stracieri, Fabiano Pieroni, D. F. Godoi, Euripides Ferreira, Mariana Coutinho
Publikováno v:
Revista Brasileira de Reumatologia. 45
Nesta revisao, discutem-se os resultados dos transplantes de celulas-tronco hematopoeticas (TCTH) para doencas reumaticas graves e refratarias a terapia convencional realizados no Brasil. Sao analisados os resultados preliminares obtidos no Brasil co
Autor:
R S Medeiros, E Zambon, L.A.G. SIlva, A. Sakashita, Dalton de Alencar Fischer Chamone, P. Dorlhiac, M. Ostronoff, M.F. Campos, C M Massumoto, M. C. A. Macedo, S. Mizukami, Alfredo Mendrone, Frederico Luiz Dulley
Publikováno v:
Revista da Associação Médica Brasileira v.43 n.2 1997
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 43, Issue: 2, Pages: 93-98, Published: JUN 1997
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira, Volume: 43, Issue: 2, Pages: 93-98, Published: JUN 1997
A infusão de células hematopoéticas totipotentes criopreservadas permite a recuperação da hematopoese após quimioterapia mieloablativa. OBJETIVO. A formação de cristais de gelo durante o processo de congelamento é o fator principal que causa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::938489a66c9c0854ae9b3587c7ac7148
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42301997000200003
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42301997000200003
Autor:
C M, Massumoto, S, Mizukami, M F, Campos, L A, Silva, A, Mendrone Júnior, A, Sakashita, E, Zambon, M, Ostronoff, M C, Macedo, R, Medeiros, P, Dorlhiac, D, Chamone, F, Dulley
Publikováno v:
Revista da Associacao Medica Brasileira (1992). 43(2)
The cryopreservation of hematopoietic stem cells can be used for rescuing the hematopoiesis after high dose chemotherapy.The ice crystal formation during the freezing procedure is the key point that can be harmful to the cells. The cryopreservation o
Autor:
M. C. A. Macedo, A C M Silva, C M Massumoto, Jussara Bianchi Castelli, Frederico Luiz Dulley, M. Ostronoff, Dalton de Alencar Fischer Chamone, E Zambon, Clarisse Martins Machado
Publikováno v:
Bone marrow transplantation. 19(1)
Nocardiosis has rarely been described after BMT. When the doses of immunosuppressive therapy were tapered, a 46-year-old BMT recipient developed chronic graft-versus-host disease (GVHD) and immunosuppressive drugs were increased. Sixteen days later t
Autor:
M, Ostronoff, C, Soussain, E, Zambon, A, Moran, J P, Droz, J, Bosq, C, Bayle, J M, Cosset, M, Hayat
Publikováno v:
Nouvelle revue francaise d'hematologie. 37(5)
The present report concerns a retrospective study of 16 patients with localized intermediate- or high-grade non-Hodgkin's lymphoma of the testis treated in one institution from 1973 to 1990. Ann Arbor stage of disease was IE in 11 and IIE in 5 cases.
Autor:
José-L. Pico, Jean Bourhis, Dominique Maraninchi, Patrice Viens, Jean Pierre Droz, M. Hayat, Catherine Lhommé, Michel Chazard, M Ostronoff, Edmilson Zambon, Françoise Beaujean, A. Ibrahim
Publikováno v:
European journal of cancer (Oxford, England : 1990). (10)
25 patients with poor-prognosis malignancies were treated with a combination of fixed-dose etoposide (1750 mg/m 2 ), cyclophosphamide (6400 mg/m 2 ) and escalating doses of carboplatin (from 800 to 1600 mg/m 2 ) followed by autologous bone marrow tra
Autor:
M, Ostronoff, C, Soussain, E, Zambon, A, Ibrahim, J, Bosq, C, Bayle, J L, Pico, E, Gilles, A, Moran, J P, Droz
Publikováno v:
Nouvelle revue francaise d'hematologie. 34(5)
The prognosis of Burkitt's lymphoma is generally considered to be poor, particularly in the advanced stages of the disease. Although recent chemotherapy protocols have given high rates of cure in children, there are few such reports concerning adults